Combined with our trafficking and insulin release results, these data show a canonical role for -arrestin recruitment in promoting GLP-1R endocytosis and desensitization
In Q1 2025, 24% of patients with both diabetes/obesity and OSA initiated a GLP-1 therapy within six months of diagnosis, compared to 18% of patients with diabetes/obesity alone
In a subgroup of participants with indicators of prediabetes, some of the two-drug combination therapy groups had 100% reversion to normoglycemia among participants with prediabetes at baseline, essentially moving them to a nonprediabetes status
Meta-analysis reveals reproducible gut microbiome alterations in response to a high-fat diet (in Eng)
Recalca que las afirmaciones de beneficios en webs de doping carecen de respaldo cientfico y que su uso no tiene justificacin mdica vlida)
The widespread empty-stomach misconception may stem from early GLP-1 education materials that grouped all GLP-1 medications together